Package Leaflet: Information for the User
omeprazole cinfa 40 mg hard capsules
Omeprazole
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1.What is omeprazole cinfa and what it is used for
2.What you need to know before you start taking omeprazole cinfa
3.How to take omeprazole cinfa
4.Possible side effects
5.Storage of omeprazole cinfa
6.Contents of the pack and additional information
Omeprazole cinfa contains the active ingredient omeprazole. It belongs to a group of medicines called “proton pump inhibitors”. These medicines act by reducing the amount of acid produced by the stomach.
Omeprazole is used to treat the following diseases:
In adults:
In children:
Children over 1 year of age and ≥ 10 kg
Children over 4 years of age and adolescents
Do not take omeprazole:
Do not take omeprazole if you fall into any of the above categories. If you are unsure, speak with your doctor or pharmacist before taking omeprazole.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Omeprazole Cinfa 40 mg:
Severe cutaneous reactions have been reported in relation to omeprazole treatment, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized pustular psoriasis (AGPP). Stop taking omeprazole and consult your doctor immediately if you experience any of these symptoms related to severe cutaneous reactions described in section 4.
Omeprazole may mask symptoms of other diseases. Therefore, if you experience any of the following symptoms before starting to take omeprazole or during treatment, consult your doctor immediately:
If you take omeprazole for a long period (more than 1 year), your doctor will likely perform regular check-ups. Inform your doctor of any new or unusual symptoms and circumstances whenever you visit.
Taking a proton pump inhibitor like omeprazole, especially for more than a year, may slightly increase the risk of fractures in the hip, wrist, or spine. Inform your doctor if you have osteoporosis or are taking corticosteroids (which can increase the risk of osteoporosis).
Omeprazole may cause kidney inflammation. Signs and symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. Inform your doctor of these signs.
If you experience a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt omeprazole treatment. Remember to mention any other symptoms you notice, such as joint pain.
Children
Some children with chronic diseases may require long-term treatment, although it is not recommended. Do not administer this medication to children under 1 year of age or <10>
Other medications and omeprazole cinfa
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This includes medications obtained without a prescription.Omeprazolemay affect the mechanism of action of some medications, and some medications may affectomeprazole.
Do not take omeprazole if you are taking a medication that containsnelfinavir(used to treat HIV infection).
Inform your doctor or pharmacist if you are taking any of the following medications:
If your doctor has prescribed you amoxicillin and clarithromycin, in addition to omeprazole, to treat ulcers caused by Helicobacter pylori infection, it is essential to inform your doctor of any other medications you are taking.
Omeprazole intake with food and beverages
See section 3.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Omeprazole passes into breast milk but is unlikely to affect the baby when used in therapeutic doses.
Your doctor will decide if you can take omeprazole if you are breastfeeding.
Driving and operating machinery
Omeprazole is unlikely to affect your ability to drive or use tools or machines. However, side effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or operate machinery.
Omeprazole cinfa contains saccharose and sodium
Omeprazole cinfa contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will tell you how many capsules to take and for how long. This will depend on your condition and age.
The recommended dose is described below:
Use in adults
Treatment of symptoms of gastroesophageal reflux disease (GERD), such asheartburn and acid regurgitation:
Treatment ofulcers of the upper part of the small intestine (duodenal ulcer):
Treatment ofstomach ulcers (gastric ulcer):
Preventionof the recurrence ofstomach and duodenal ulcers:
Treatment of stomach and duodenal ulcers caused by NSAIDs (nonsteroidal anti-inflammatory drugs):
Prevention of stomach and duodenal ulcersduring the administration ofNSAIDs:
Treatment ofulcers causedby the infectionbyHelicobacter pyloriandprevention of its recurrence:
Treatment of excess acid in the stomach caused by atumor in the pancreas (Zollinger-Ellison syndrome):
Use in childrenand adolescents
Treatment of symptoms of gastroesophageal reflux disease (GERD), such asheartburn and acid regurgitation:
Treatment ofulcers causedby the infectionbyHelicobacter pyloriand prevention of its recurrence:
How to take this medication
What to do if you or your child have trouble swallowing the capsules
If you or your child have trouble swallowing the capsules:
If you take more omeprazole cinfa than you should
If you have taken moreomeprazolethan prescribed by your doctor, consult your doctor or pharmacist immediately. You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If you forget to takeomeprazole cinfa
If you forget to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to make up for the missed doses.
If you interrupt the treatment with omeprazole cinfa
Do not stop taking omeprazole without first talking to your doctor or pharmacist.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following rare or very rare but serious side effects, stop taking omeprazole cinfa and consult your doctor immediately:
Other side effects are:
Frequent side effects (may affect up to 1 in 10 people)
Less frequent side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Unknown frequency (cannot be estimated from available data)
In very rare cases, omeprazole cinfa may affect white blood cells in the blood and cause immunodeficiency. If you have an infection with symptoms such as fever with a very deteriorated general condition or fever with symptoms of local infection, such as neck pain, throat pain, or mouth pain or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential to provide information about the medication you are taking at that time.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Store below 30°C.
Store in the original packaging to protect it from moisture.
Store below 25°C.
Store in the original packaging to protect it from moisture.
No special storage conditions are required.
Keep the bottle perfectly closed to protect it from moisture.
Composition of omeprazole cinfa
The active ingredient is omeprazole. Omeprazole cinfa 40 mg hard-gastrorresistant capsules contain 40 mg of omeprazole.
The other components are sugar spheres (saccharose and cornstarch), hypromellose (E-464), talc (E-553b), titanium dioxide (E-171), anhydrous disodium hydrogen phosphate (E-339 ii), sodium lauryl sulfate, polisorbate 80, copolymer of methacrylic acid and ethyl acrylate, triethyl citrate (E-1505). Capsule: gelatin, titanium dioxide (E-171),printing ink (iron oxide black (E-172), potassium hydroxide and shellac).See section 2 omeprazole cinfa contains saccharose.
Appearance of the product and contents of the pack
Omeprazole cinfacapsules are hard gelatin capsules of white opaque colormarked with “OM 40”containing spherical granules.
HDPE white bottle with cap and safety ring equipped with a desiccant agent: 14, 28, 90 and 100 capsules.
Al/Al blister: 14 and 28 capsules
PVC-PVDC/Al blister: 14, 28 and 30 capsules.
Only some pack sizes may be marketed.
Marketing authorization holder and responsible person for manufacturing
Marketing authorization holder
Cinfa Laboratories, S.A.
Olaz-Chipi Road, 10. Areta Industrial Estate
31620 Huarte (Navarra) - Spain
Responsible person for manufacturing
Cinfa Laboratories, S.A.
Olaz-Chipi Road, 10. Areta Industrial Estate
31620 Huarte (Navarra) – Spain
or
TOWA PHARMACEUTICAL EUROPES.L.
Sant Martí Street, 75-97
Martorelles, 08107 Barcelona
Spain
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Germany: Omeplis 40 mgmagensaftresistente Hartkapseln
Netherlands:Omecat 40 mg maagsapresistente capsule, hard
Romania:Omez 40 mg capsule gastrorezistente
Spain:Omeprazol cinfa 40 mg cápsula dura gastrorresistente
United Kingdom: 40 mg gastro-resistant capsule, hard
Last review date of this leaflet:April 2023
Detailed information about this medicinal product is available on the website of theSpanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
You can access detailed and updated information about this medicinal product by scanning with your mobile phone (smartphone) the QR code included in the leaflet and packaging. You can also access this information at the following internet address:https://cima.aemps.es/cima/dochtml/p/78891/P_78891.html
QR code to:https://cima.aemps.es/cima/dochtml/p/78891/P_78891.html
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.